NK cells produce high levels of IL-10 early after allogeneic stem cell transplantation and suppress development of acute GVHD.
暂无分享,去创建一个
C. Craddock | S. Nagra | R. Malladi | J. Zuo | F. Kinsella | Y. T. Chan | Jane Nunnick | C. Inman | Joanne E. Croudace | P. Moss | W. Croft | Jusnara Begum | Ben Abbotts | Luke Maggs
[1] F. Claas,et al. Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia , 2016, Science Translational Medicine.
[2] G. Hill,et al. Functional Reconstitution of Natural Killer Cells in Allogeneic Hematopoietic Stem Cell Transplantation , 2016, Front. Immunol..
[3] Y. Kodera,et al. Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey , 2016, Bone Marrow Transplantation.
[4] D. Doherty,et al. Circulating CD56dim natural killer cells and CD56+ T cells that produce interferon‐γ or interleukin‐10 are expanded in asymptomatic, E antigen‐negative patients with persistent hepatitis B virus infection , 2015, Journal of viral hepatitis.
[5] S. Granjeaud,et al. Reconstitution of natural killer cells in HLA-matched HSCT after reduced-intensity conditioning: impact on clinical outcome. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[6] M. Pasquini,et al. Acute graft-versus-host disease: a bench-to-bedside update. , 2014, Blood.
[7] Maria F. Fragoso,et al. Proliferation Conditions Promote Intrinsic Changes in NK Cells for an IL-10 Response , 2014, The Journal of Immunology.
[8] Xiao-jun Huang,et al. Immune reconstitution after haploidentical hematopoietic stem cell transplantation. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[9] T. Fehniger,et al. Cytokine activation induces human memory-like NK cells. , 2012, Blood.
[10] A. Oxenius,et al. IL-10 Suppression of NK/DC Crosstalk Leads to Poor Priming of MCMV-Specific CD4 T Cells and Prolonged MCMV Persistence , 2012, PLoS pathogens.
[11] L. Moretta,et al. Dendritic Cell Editing by Activated Natural Killer Cells Results in a More Protective Cancer-Specific Immune Response , 2012, PloS one.
[12] A. Barrett,et al. Selectively T cell-depleted allografts from HLA-matched sibling donors followed by low-dose posttransplantation immunosuppression to improve transplantation outcome in patients with hematologic malignancies. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[13] Joseph C. Sun,et al. Homeostatic proliferation generates long-lived natural killer cells that respond against viral infection , 2011, The Journal of experimental medicine.
[14] M. Caligiuri,et al. Innate or Adaptive Immunity? The Example of Natural Killer Cells , 2011, Science.
[15] M. Altfeld,et al. IL-10 induces aberrant deletion of dendritic cells by natural killer cells in the context of HIV infection. , 2010, The Journal of clinical investigation.
[16] I. Yakoub-Agha,et al. Plasma levels of IL-7 and IL-15 in the first month after myeloablative BMT are predictive biomarkers of both acute GVHD and relapse , 2010, Bone Marrow Transplantation.
[17] C. Karp,et al. Systemic but not local infections elicit immunosuppressive IL-10 production by natural killer cells. , 2009, Cell host & microbe.
[18] B. Sandmaier,et al. Defining the intensity of conditioning regimens: working definitions. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[19] J. Schold,et al. The relationship between circulating natural killer cells after reduced intensity conditioning hematopoietic stem cell transplantation and relapse-free survival and graft-versus-host disease , 2008, Haematologica.
[20] Antal Rot,et al. CCR7 and its ligands: balancing immunity and tolerance , 2008, Nature Reviews Immunology.
[21] E. Riley,et al. IL-10: The Master Regulator of Immunity to Infection , 2008, The Journal of Immunology.
[22] Marcela R. Uribe,et al. Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia , 2007, Leukemia.
[23] K. Rezvani,et al. Absolute lymphocyte count on day 30 is a surrogate for robust hematopoietic recovery and strongly predicts outcome after T cell-depleted allogeneic stem cell transplantation. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[24] D. Tough,et al. In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection , 2007, Immunology.
[25] W. Shlomchik,et al. Graft-versus-host disease , 2007, Nature Reviews Immunology.
[26] P. Parham,et al. The expanded cattle KIR genes are orthologous to the conserved single-copy KIR3DX1 gene of primates , 2007, Immunogenetics.
[27] M. Mack,et al. Gut-associated lymphoid tissue-primed CD4+ T cells display CCR9-dependent and -independent homing to the small intestine. , 2006, Blood.
[28] L. Moretta,et al. Early liaisons between cells of the innate immune system in inflamed peripheral tissues. , 2005, Trends in immunology.
[29] L. Zitvogel,et al. Natural-killer cells and dendritic cells: "l'union fait la force". , 2005, Blood.
[30] Y. Sasaki,et al. Cytokine Profile of Natural Killer Cells in Early Human Pregnancy , 2005, American journal of reproductive immunology.
[31] A. Bacigalupo. Antilymphocyte/thymocyte globulin for graft versus host disease prophylaxis: efficacy and side effects , 2005, Bone Marrow Transplantation.
[32] A. Svejgaard,et al. Chimerism studies in HLA-identical nonmyeloablative hematopoietic stem cell transplantation point to the donor CD8(+) T-cell count on day + 14 as a predictor of acute graft-versus-host disease. , 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[33] L. Bisset,et al. Reference values for peripheral blood lymphocyte phenotypes applicable to the healthy adult population in Switzerland , 2004, European journal of haematology.
[34] J. Dorfman,et al. Turnover and Proliferation of NK Cells in Steady State and Lymphopenic Conditions1 , 2004, The Journal of Immunology.
[35] M. Farrar,et al. In Vivo Survival and Homeostatic Proliferation of Natural Killer Cells , 2003, The Journal of experimental medicine.
[36] M. Caligiuri,et al. In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells. , 2002, Blood.
[37] Katia Perruccio,et al. Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants , 2002, Science.
[38] H. Ljunggren,et al. Targeting of human dendritic cells by autologous NK cells. , 1999, Journal of immunology.
[39] S. Rafii,et al. The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. , 1998, Blood.
[40] D. Taub,et al. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation. , 1998, The Journal of clinical investigation.
[41] H. Kanegane,et al. Production of IL-10 by human natural killer cells stimulated with IL-2 and/or IL-12. , 1998, Journal of immunology.
[42] J. Klein,et al. IBMTR Severity INDEX FOR GRADING ACUTE GRAFT‐VERSUS‐HOST DISEASE: RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADE , 1997, British journal of haematology.
[43] R. Marcus,et al. Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse. , 1986, Bone marrow transplantation.
[44] H. Ljunggren,et al. Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy , 1986, Nature.
[45] S. Orkin,et al. Phenotype of recovering lymphoid cell populations after marrow transplantation , 1985, The Journal of experimental medicine.
[46] G. Trinchieri,et al. Human natural killer cells. , 1979, Transplantation proceedings.
[47] P. Neiman,et al. One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. , 1977, Blood.
[48] M. Martelli,et al. NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation. , 2008, Blood cells, molecules & diseases.
[49] L. Thomsen,et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. , 2004, Nature immunology.